Financials

News Ideas Technicals

1349 fundamentals

Overview Statements Statistics Dividends Earnings Revenue

An in-depth look to SHANGHAI FUDAN-ZHANGJIAN BIO-PHARM operating, investing, and financing activities

1349 free cash flow for Q1 24 is 36.34 M HKD. For 2023, 1349 free cash flow was -30.89 M HKD and operating cash flow was 78.47 M HKD.

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

‪0.00‬

Cash from operating activities

Cash from investing activities

Cash from financing activities

Income statement Balance sheet Cash flow

Currency: HKD

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

TTM

YoY growth

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—